Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Katharine, Furst"'
1
Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis
Autor: Katharine Furst, Linda Stein, Sharon F. Levy, Keith Loven
Publikováno v: Clinical Therapeutics. 24:990-1000
Background: A new 0.5% fluorouracil cream has been developed that provides an alternative to the more highly concentrated topical formulations of fluorouracil that are currently available. Objective: This was a comparison of the tolerability and effi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ab88f1ad04d10af0464d06b2764e644
https://doi.org/10.1016/s0149-2918(02)80012-1
Zobrazit plný text záznamu
2
A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis
Autor: Katharine Furst, Wendy Chern, Sharon F. Levy
Publikováno v: Clinical Therapeutics. 23:908-920
Background: Systemic absorption of topical fluorouracil, although usually low, may vary as a result of the specific skin disease, product formulation, and other factors. Objective: The present study was conducted to determine the pharmacokinetic prof
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed94476f5c54033244f3971051e0f73
https://doi.org/10.1016/s0149-2918(01)80078-3
Zobrazit plný text záznamu
3
Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial
Autor: Jonathan S. Weiss, Christine Vandepol, Katharine Furst, Joseph L. Jorizzo, Sharon F. Levy
Publikováno v: Archives of dermatology. 140(7)
No long-term randomized controlled clinical trial has compared the efficacy of cryosurgery alone vs cryosurgery following fluorouracil applications for the treatment of actinic keratosis.To determine the 6-month outcome of a 1-week course of 0.5% flu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4426a68135239cf0b73d063f2b3933
https://pubmed.ncbi.nlm.nih.gov/15262691
Zobrazit plný text záznamu
4
Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis
Autor: Joseph, Jorizzo, Daniel, Stewart, Alicia, Bucko, Steven A, Davis, Paul, Espy, Peter, Hino, David, Rodriguez, Ronald, Savin, Dow, Stough, Katharine, Furst, Margaret, Connolly, Sharon, Levy
Publikováno v: Cutis. 70(6)
The efficacy and safety of a new 0.5% fluorouracil topical cream were compared with vehicle control for the treatment of actinic keratosis (AK). Active treatment applied once daily for 1, 2, or 4 weeks was more effective than vehicle control in achie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d4002640907a598d96f9cf93321b3a75
https://pubmed.ncbi.nlm.nih.gov/12502122
Zobrazit plný text záznamu
5
Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks
Autor: Jonathan, Weiss, Alan, Menter, Oscar, Hevia, Terry, Jones, Mark, Ling, Toivo, Rist, Janet, Roberts, Joel S, Shavin, Jerald, Sklar, Guy, Webster, Margaret, Connolly, Katharine, Furst, Sharon, Levy
Publikováno v: Cutis. 70
New therapeutic options would benefit patients with actinic keratosis (AK), a precancerous condition that is a significant health concern. The efficacy and safety of a microsphere-based formulation of 0.5% fluorouracil cream were evaluated in a rando
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bac6d931adf84b0c42dafb4103839108
https://pubmed.ncbi.nlm.nih.gov/12353677
Zobrazit plný text záznamu
6
A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream
Autor: Sharon, Levy, Katharine, Furst, Wendy, Chern
Publikováno v: Cutis. 70
Recent in vitro and in vivo studies compared the absorption of a 0.5% fluorouracil cream with that of a 5% fluorouracil cream, following topical application to the skin. Both studies demonstrated that fluorouracil is minimally absorbed into the syste
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::110adcc33e645b9da53729431fb82a56
https://pubmed.ncbi.nlm.nih.gov/12353676
Zobrazit plný text záznamu
7
A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation
Autor: Katharine Furst, Wendy Chern, Sharon F. Levy
Publikováno v: Clinical therapeutics. 23(6)
Background: Topical fluorouracil has proven efficacy in the treatment of actinic keratosis. The systemic absorption of various topical formulations of fluorouracil varies, however, and may be affected by the concentration and delivery system used. Ob
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774ea12ecd4ddaf859c8bd3a122c75e6
https://pubmed.ncbi.nlm.nih.gov/11440289
Zobrazit plný text záznamu
9
A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopaus
Autor: Katharine Furst, David F. Archer, Marie-Paule Dain, Diane Tipping, Christine Vandepol
Publikováno v: Clinical Cornerstone. 2:53
Objective: To determine whether a continuous estradiol-norethindrone acetate transdermal delivery system reduces incidence of endometrial hyperplasia in postmenopausal women more than transdermal estradiol (E2) alone. Methods: Six hundred twenty-five
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9d347ea7d5964633bef137fcac36a18
https://doi.org/10.1016/s1098-3597(99)90006-6
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje